Related Experiment Video

Updated: May 27, 2025

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

21.0K

An ACTH-Producing Neuroendocrine Tumor: Clinical Course of Multidisciplinary Therapy Including Peptide Receptor

Tomonobu Koizumi1, Ai Sato2, Kohei Kitajima2

  • 1Shinshu Cancer Center, Shinshu University Hospital, Matsumoto, Japan.

Case Reports in Oncology
|February 21, 2025
PubMed
Summary

Peptide receptor radionuclide therapy (PRRT) effectively treated a rare adrenocorticotropic hormone (ACTH)-producing neuroendocrine tumor (NET). Careful management is crucial to address potential hormonal crises during PRRT for these complex NETs.

Keywords:
177Lu-DOTATATECushing’s syndromeEctopic ACTH syndromeTumor resection

More Related Videos

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

473
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

375

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463